Publication Date
2-27-2023
Journal
ELife
DOI
10.7554/eLife.83806
PMID
36848184
PMCID
PMC9977283
PubMedCentral® Posted Date
2-27-2023
PubMedCentral® Full Text Version
Post-print
Published Open-Access
yes
Keywords
Rett Syndrome, Mental Retardation, X-Linked, Growth Differentiation Factors, Aging, Disease Models, Animal, Bone Morphogenetic Proteins, Nervous System Physiological Phenomena, Mice, Animals, Methyl-CpG-Binding Protein 2
Abstract
Loss- and gain-of-function of MeCP2 causes Rett syndrome (RTT) and MECP2 duplication syndrome (MDS), respectively. MeCP2 binds methyl-cytosines to finely tune gene expression in the brain, but identifying genes robustly regulated by MeCP2 has been difficult. By integrating multiple transcriptomics datasets, we revealed that MeCP2 finely regulates growth differentiation factor 11 (Gdf11). Gdf11 is down-regulated in RTT mouse models and, conversely, up-regulated in MDS mouse models. Strikingly, genetically normalizing Gdf11 dosage levels improved several behavioral deficits in a mouse model of MDS. Next, we discovered that losing one copy of Gdf11 alone was sufficient to cause multiple neurobehavioral deficits in mice, most notably hyperactivity and decreased learning and memory. This decrease in learning and memory was not due to changes in proliferation or numbers of progenitor cells in the hippocampus. Lastly, loss of one copy of Gdf11 decreased survival in mice, corroborating its putative role in aging. Our data demonstrate that Gdf11 dosage is important for brain function.
Comments
Associated Data